GEA
ARKG icon

Glen Eagle Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Glen Eagle Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.3K Buy
768
+10
+1% +$293 ﹤0.01% 564
2025
Q4 		$22K Hold
758
– – ﹤0.01% 566
2025
Q3 		$21.1K Hold
758
– – ﹤0.01% 570
2025
Q2 		$18.5K Hold
758
– – ﹤0.01% 565
2025
Q1 		$15.7K Sell
758
-11
-1% -$276 ﹤0.01% 576
2024
Q4 		$18.1K Hold
769
– – ﹤0.01% 562
2024
Q3 		$19.7K Sell
769
-27
-3% -$688 ﹤0.01% 559
2024
Q2 		$18.7K Buy
796
+23
+3% +$580 ﹤0.01% 548
2024
Q1 		$22.2K Sell
773
-19
-2% -$571 ﹤0.01% 532
2023
Q4 		$26K Buy
792
+272
+52% +$7.4K 0.01% 501
2023
Q3 		$14.5K Hold
520
– – ﹤0.01% 572
2023
Q2 		$17.7K Hold
520
– – ﹤0.01% 548
2023
Q1 		$15.6K Hold
520
– – ﹤0.01% 545
2022
Q4 		$14.7K Hold
520
– – ﹤0.01% 540
2022
Q3 		$17.1K Hold
520
– – 0.01% 510
2022
Q2 		$16.4K Buy
520
+150
+41% +$5.25K ﹤0.01% 542
2022
Q1 		$17K Hold
370
– – ﹤0.01% 537
2021
Q4 		$22.7K Buy
370
+18
+5% +$1.24K 0.01% 494
2021
Q3 		$26.3K Hold
352
– – 0.01% 500
2021
Q2 		$32.6K Hold
352
– – 0.01% 456
2021
Q1 		$31.2K Buy
+352
New +$34.9K 0.01% 430

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Glen Eagle Advisors's ARKG Position: Q1 2026 in Review

Glen Eagle Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 1.3% in Q1 2026, buying an estimated $293 and bringing the position to 768 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #564.

Glen Eagle Advisors first reported a position in ARKG in Q1 2021 and has held it in 21 quarters since. The position peaked at $32.6K in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Glen Eagle Advisors held 768 shares of ARK Genomic Revolution ETF worth $20.3K as of Q1 2026.
  • Glen Eagle Advisors bought 10 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $293.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #564 holding.
  • Glen Eagle Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 21 quarters since.
  • Glen Eagle Advisors's ARK Genomic Revolution ETF position peaked at $32.6K in Q2 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.